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Abstract
It has been some forty years since the first publications emerged on the biological effects of low-powered
lasers. Therapies with this kind of light have far outgrown their infancy and are now showing themselves to
be a treatment that has come of age. The question is no longer whether low level laser treatment is effective
but, far more interestingly, debates are being held about its most effective use. In the United States of
America, Australia, the United Kingdom and Scandinavia, low level laser therapy (LLLT) is a well-accepted and
widely-used form of treatment for a wide range of medical conditions. In the Netherlands, LLLT is mainly
known for its success in helping people to stop smoking. LLLT has so much more to offer.
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Introduction
The word “laser” is an acronym for “light ampli-
fication by stimulated emission of radiation”. Nor-
mal light has a broad spectrum with many frequen-
cies and intensities. Laser light consists of only one
frequency (wavelength) and intensity. Laser light is,
therefore, coherent, monochromatic and focused;
by using a technique that stimulates emission, light
can be amplified (intensified) [1]. To put it another
way, we can produce light with an enormous
amount of power.
The scientific use of light waves
The history of light therapy goes back a long
way to the dark ages but it was only in the 20th
century that the scientific use of certain light waves
was used to improve physical conditions. It was
Albert Einstein who predicted the existence of the
laser in 1917 on theoretical grounds but the first
effective laser was not made until many decades
later. In 1960 Theodore Maiman, a physicist, wrote
his first publication on laser radiation in relation-
ship to health. In 1967, a Hungarian Professor of
Medicine and surgeon named Endre Mester dis-
covered that accelerated wound healing occurred
with low intensity laser irradiation of wounds. Dr
Mester is considered to be the father of laser thera-
py. He published multiple papers throughout the
1960s, 1970s and 1980s on the scientific investiga-
tion and therapeutic application of the ruby and
helium neon lasers. Over the past 15 years the laser
technique has played an important role in many
kinds of medical discipline. The use of the laser in
medicine is divided into that of high-powered and
low-powered lasers, the latter also known as low
level laser therapy (LLLT), the difference lying in the
energy emitted. The action of LLLT is on firm ground,
supported by over 2,500 scientific studies performed
in many universities.
The high-powered laser (HPL)
High-powered lasers aim to destroy tissue and
are used in dermatology, gastro-enterology, eye sur-
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gery, surgical and other disciplines. High-powered
lasers are medically invasive and should only be used
by doctors, as they can not only harm healthy tis-
sue, but may also cause additional damage to ail-
ing tissues.
The low level laser (LLL)
Low-powered lasers (low level lasers) have the
same characteristics as HP lasers but their power
output is greatly reduced. Low level laser denotes
a low rise in temperature (less than1°C). LLLT is a
safe type of light therapy that only influences
pathological conditions or zones and normal tis-
sue is not subject to any change as a result. LLLT is,
therefore, an accepted form of therapeutic sup-
port for many kinds of treatments, hence its use in
physiotherapy, podiatry, dentistry, dermatology,
general practice, acupuncture, addiction medicine,
sports medicine and veterinary procedures. Beau-
ticians have also used LLL successfully in the treat-
ment of, for example, acne, couperosis and rosa-
cea.
How does LLL work?
Low level laser light is basically a ray of photons
(small packets of energy) that is absorbed by the
tissues and transformed in the mitochondria of the
tissue cells into cell energy.
The LLL has the following physiological effects:
— increased growth factor response;
— increased ATP synthesis;
— increased cell proliferation;
— increased cell motility;
— increased angiogenesis;
— matrix remodelling is enhanced;
— modulation of the metabolism of neurochemi-
cals i.e. serotonin and endorphins;
— reduced nociceptor activity;
— increased immune system response.
These physiological effects act on various cell
types, such as macrophages, fibroblasts, endothe-
lial cells and mast cells. This leads to increased and
accelerated wound healing, pain reduction and in-
creased immune response.
The setting determines the efficacy
In order to achieve the optimum effect for every
condition, it is important to use the appropriate
wavelength and the correct energy dose, which
change with every type of treatment. Too high a
dose will not produce the desired effect; too low
will effect no change at all. The admission of pulsed
light at a specific frequency also appears to be im-
portant. All these factors not only determine whether
the laser energy reaches the tissues but also their
response. This is one of the main reasons why, in
the past and even now, many scientific studies have
failed to demonstrate the positive effects of the
LLL, leading to conclusions such as the LLLT not
being scientifically proven to work. Inaccurate mea-
surements and the incorrect reporting of dosages
have been major shortcomings of phototherapy
(LLLT) studies. As many as 30% of the reports pub-
lished in this field either lack the relevant informa-
tion needed to determine a dosage or report dos-
ages that are altogether inaccurate. The high preva-
lence of dosage-related errors in published reports
suggests that dosage determination errors are com-
mon among clinicians and other end users.
An example of the use and effect
of laser probes
The example of probes and their use in LLLT is
shown on Table 1.
In most cases, one single probe and a cluster
were used in the same area.
Pulsed light or continuous light?
That is the question
If the laser therapy is intended for wound heal-
ing, multi-pulsed light at low frequencies (2.5–20
Hz) provides the best results; if it is for pain control,
multi-pulsed light at medium frequencies (73–700
Hz) are used; and to ease chronic inflammations
and painful joints, multi-pulsed high frequencies
(5–20 KHz) should be used. This turnes chronic in-
flammation and pain into an acute type. Than in
second instance, by using low frequency pulsing
(2,5–20Hz) the inflammation or pain subsides.
Side-effects and contraindications
Since LLLT is a non-invasive, non-destructive tech-
nique, there are almost no side-effects. The follow-
ing contraindications are usually mentioned.
Direct irradiation of the eyes
Class 3b lasers are potentially harmful to the
retina — though retinal damage is highly unlikely.




Laser is contra-indicated for use over the preg-
nant uterus. It may be used on the pregnant wom-
an as an adjunct to the other modalities being
used for the treatment of back pain or other com-
plaints.
Carcinoma
Although research has shown an increase in ap-
optosis in neoplastic cells and no effect on non-
neoplastic cells after infrared pulsed laser treatment
[11], generally the experts advise not to use laser
over any known primary or secondary lesions. Laser
treatment may be given for pain and other symp-
toms relief during the terminal stages of the illness
with the full consent of both patient and consult-
ant involved.
Thyroid
Laser should not be used over the thyroid gland.
Haemorrhage
It is conceivable that laser-mediated vasodila-
tion may worsen the haemorrhage.
Immune suppressant drugs
Laser therapy is contra-indicated for patients on
these drugs
Treatment over sympathetic ganglia,
the vagus nerves and cardiac region
in patients with heart disease
Laser therapy may significantly alter neural func-
tion, and is therefore contra-indicated over these
regions in patients with heart disease.
LLLT and pain control
The LLL has been used for many years with posi-
tive results both in rheumatology and physiothera-
py, and a number of studies have confirmed its
beneficial effects [2–5].
LLLT and palliative care
In palliative care the main goal is to provide
optimum relief of suffering in all dimensions, wheth-
er physical, psychological, psychosocial or spiritual.
In this setting, the main areas for physical prob-
lems are pain, nausea and vomiting, dyspnoea, con-
stipation and diarrhoea but many other conditions
arise in the terminal phase. Due to the bedridden
state of many of the patients, decubitus or pressure
sores are a constant worry but other pre-existing
conditions, such as joint pain due to arthritis, might
also need attention. Chronic venous ulcers present
a considerable reduction in a patient’s quality of
life and, once attended to, can greatly improve some-
one’s sense of well-being, even in a palliative set-
ting. In addition to the above, treatments in oncol-
ogy often have unpleasant side effects (nausea, oral
mucositis, xerostomia and severe pain due to radio-
therapy to the head and neck).
Since LLLT is painless and easy to perform, it can
be highly beneficial in palliative care. LLLT is cur-
rently used in our hospice as a complementary treat-
ment, for pain relief, prevention and treatment of
decubitus and wound healing. Since the laser appa-
ratus that we use (Omega XP) has an acupuncture
mode, it is also possible to stimulate certain acu-
puncture points to treat conditions such as nausea.
Table 1. Example of probes and their use in LLLT
Probe Penetrating effect Cellular response Used for
675 nm Of its power, only 5% Good growth factor response Ulcers and wounds
30 mW penetrates  the skin and below Post-operative  procedures
Bacterial static effect Skin conditions
Infection control
Virus static effect  Herpes labialis
20% penetrates Excellent growth Tissue repair underneath the dermis
subcutaneously factor response Soft tissue/sports injury
820 nm More effective penetration Endorphin delivery Acupuncture point stimulation
 and energy delivery
200 mW Proven energy delivery up to Higher serotonin levels Trigger point therapy
3 to 4 cm deep in the tissues Pain relief
Warts
Smoking cessation
Cluster Series of wave-lengths Excellent growth factor Ulcers and wounds
combined for excellent response over larger areas Post-operative procedures
penetration and radiation volume Skin conditions
Infection control
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Trigger point stimulation  can also lead to better
pain control.
Our results with the use of the LLL in our hospice
are at least promising and in some cases even ex-
traordinarily positive, although we are, of course,
referring here to individual cases and by no means
to scientific research studies. In general, it is very
hard to conduct randomized, controlled, double
blind cross over studies in such a setting but hos-
pice care is primarily concerned with making the
maximum effort for the optimal relief of suffering.
A literature search to discover whether the LLL is
being used elsewhere in palliative care also showed
some promising results, such as those mentioned
below.
Beneficial effects of the LLL were described
for the prevention and treatment for radiation-
induced mucositis in head and neck cancer [6].
Some literature described the improvement of
quality of life [7].
All patients tolerated the laser treatment with-
out any adverse effect or reactions. The result
showed a significant difference in pain and mucosi-
tis (p < 0.001) between the two groups. At the end
of radiotherapy (after 6 weeks) mean pain score
and mucositis grade were significantly lower (p <
0.001) in the study group compared to the control.
A positive effect was found on lymphoede-
ma secondary to breast cancer [8].
This study has found that both conservative and
LLL treatments are effective in treating lymphoede-
ma, and that many patients consider LLLT as a via-
ble treatment option.
Phototherapy improves healing of chronic
venous ulcers [9].
Ulcers treated with phototherapy healed sig-
nificantly faster than controls when compared at
day 30 (p < 0.01), day 60 (p < 0.05) and day 90 (p
< 0.001) and similarly healed faster than the pla-
cebo-treated ulcers. Medium- and large-sized ul-
cers healed significantly faster with treatment (>
40% rate of healing per month) than placebo or
control ulcers (p < 0.05). Phototherapy promotes
healing of chronic venous ulcers, particularly large
recalcitrant ulcers that do not respond to conven-
tional treatment.
Laser therapy converts diabetic wound heal-
ing to normal healing [10].
In this induced-diabetes model, wound and burn
healing were improved by 40.3% and 45%, respec-
tively, in 633-nm laser dosimetry experiments, and
diabetic wound and burn healing was accelerated
by phototherapy. LLLT is recommended, especially
after major surgery, in those with impaired healing,
such as diabetics and the elderly.
The Photomedicine and LLLT Literature Watch
produces an impressive list of articles every two
months of both basic scientific research and clinical
studies with LLL. Increasingly, the effects of laser
light are becoming apparent and, with more stan-
dardized treatment programmes, a positive future
for the general clinical use of the LLL lies ahead of
us. Palliative care is practised mainly at the end of
life (the treatment of chronic illnesses could also be
called palliative care but palliative care is usually
associated with care for the terminally ill), but that
does not mean that new techniques should not be
considered. On the contrary, any intervention that
is beneficial and does not produce side effects or
cause harm or suffering must be used to provide
optimum relief for patients.
Conclusions
Low level laser therapy is not new in clinical med-
icine, but its use in the past, with very contradictory
results, has caused its use in some countries, such
as the Netherlands, to become limited or even un-
known.
A therapeutic device is often only as effective as
the clinical skills of the end user, and some clini-
cians are similarly only as good as their tools allow
them to be. On the one hand, the World Associa-
tion for Laser Therapy (WALT) has proposed guide-
lines and standards for designing and conducting
clinical studies; on the other, there is a great need
among clinicians for effective treatment protocols.
Close cooperation between clinicians and produc-
ers of laser devices will eventually lead to the more
widely and successful use of the low level laser.
From personal experience, both in general prac-
tice and in hospice care, I am confident that LLLT
will eventually be widely used by clinicians in gener-
al practice, nursing homes and hospices.
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